Logo

American Heart Association

  36
  0


Final ID:

Commentary: Screening for Cardiac Amyloid

  • Ahmad, Faraz  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
  • Author Disclosures:
    Faraz Ahmad: DO have relevant financial relationships ; Research Funding (PI or named investigator):Pfizer:Past (completed) ; Consultant:AstraZeneca:Past (completed) ; Speaker:AstraZeneca:Past (completed) ; Speaker:Alnylam:Past (completed) ; Consultant:Alnylam Pharmceuticals:Active (exists now) ; Research Funding (PI or named investigator):Abiomed/Johnson and Johnson:Active (exists now) ; Research Funding (PI or named investigator):AstraZeneca:Active (exists now) ; Research Funding (PI or named investigator):Atman Health:Past (completed) ; Research Funding (PI or named investigator):Tempus:Active (exists now) ; Research Funding (PI or named investigator):Atman Health :Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Rewriting the Code for Cardiac Amyloid: Novel Identification, Treatment, and Cure

Monday, 11/10/2025 , 01:30PM - 02:45PM

Featured Science

More abstracts on this topic:
Updated Phase 1 Clinical Trial Outcomes of CRISPR Gene Editing With Nexiguran Ziclumeran In Patients With Transthyretin Amyloidosis With Cardiomyopathy

Gillmore Julian, Smith Derek, Haagensen Alexandra, Olbertz Joy, Zhu Peijuan, Boiselle Carri, Leung Adia, Gutstein David, Sonderfan Alison, Walsh Liron, Fontana Marianna, Solomon Scott, Taubel Jorg, Gane Edward, Pilebro Bjorn, Adams David, Claggett Brian, Kachadourian Jessica, Rocha Ricardo

Wrap: State of Cardiac Amyloid 2026

Kittleson Michelle, Mauer Matthew

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available